FDA imposes clinical hold on Ortho Regenerative's implant trial

Retrieved on: 2021-06-07 08:55:17

Tags for this article:

Medical technology

Biomedical engineering

Ortho Regenerative Technologies

Click the tags to see associated articles and topics

FDA imposes clinical hold on Ortho Regenerative's implant trial. View article details on HISWAI: https://www.medicaldevice-network.com/news/fda-ortho-clinical-hold/

Excerpt

A drug/biologic implant combination product candidate, ORTHO-R is ... Ortho Regenerative Technologies president and CEO Claude LeDuc said: “We will ... enhance the success rate of orthopaedic and sports medicine surgeries.

Article found on: www.medicaldevice-network.com

View Original Article